Inspiratory muscle training to improve breathing and core stability in bronchiectasis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Clinically stable adults with bronchiectasis aged 18–30 will participate in a supervised program using inspiratory muscle training devices targeted at improving inspiratory strength and functional breathing. Baseline and follow-up measures will include respiratory function tests, inspiratory muscle strength, and core muscle thickness and stability. Participants with recent exacerbations, recent changes in treatment, transplant history, balance‑affecting conditions, or recent supervised rehabilitation are excluded. The intervention is delivered in person at a single center with standardized training sessions and outcome measurements.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age between 18 and 30 years
* Diagnosed with bronchiectasis
* Clinically stable
* Able to cooperate
* Able to walk independently
* Volunteering to participate in the study

Exclusion Criteria:

* History of acute exacerbation and/or hospitalization within the past 4 weeks
* Change in medical treatment within the past month
* Known diagnosed conditions affecting balance (visual, auditory, vestibular, or musculoskeletal disorders)
* Participation in a supervised physiotherapy rehabilitation program within the past 6 months
* History of lung or liver transplantation

Where it's running

• Istinye University, Istanbul,
  Istanbul, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: Elif Kabasakal, MSc
• Email: elif.kabasakal@istinye.edu.tr
• Phone: +905347093738

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Chronic Respiratory Disease Participant Engagement

  This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.

  Recruiting Richmond Pharmacology Limited · London · NCT07924462

• Breathlessness in respiratory diseases: who feels it and why

  This study tests how physiology, psychology, function, and breathing patterns relate to breathlessness in people with respiratory conditions compared with healthy controls.

  Recruiting University Hospitals, Leicester · Leicester, Leicestershire · NCT07648082

• Hypertonic saline inhalation for NTM lung disease

  This trial tests whether starting inhaled 3% hypertonic saline early helps people with non-tuberculous mycobacterial lung disease feel better and clear bacteria better, compared with starting with normal saline first.

  Recruiting Taipei Veterans General Hospital, Taiwan · Taipei · NCT07647575

• Azithromycin added to usual care to see if it lowers bronchiectasis flare-ups

  This trial tests whether taking azithromycin daily for a year reduces bronchiectasis-related flare-ups in adults with non-cystic fibrosis bronchiectasis.

  Recruiting Phase 4 Assiut University · Asyut · NCT07608328

• Bronchiectasis Phenotype Identification Model for Adults

  This study tests a baseline classifier to categorize adults with non-cystic fibrosis bronchiectasis into phenotype groups using data collected over time.

  Recruiting Assiut University · Asyut, Assiut Egypt · NCT07599969

• BASE: Aiming to test a simple, objective way to gauge bronchiectasis severity and predict flare-ups

  This study tests a new BASE framework to classify how severe non-cystic fibrosis bronchiectasis is right now and see if it can predict 12 months of worsening or flare-ups.

  Recruiting Assiut University · Asyut, Asyut Egypt · NCT07599839

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.